UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): March 26, 1997
THERAGENICS CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Delaware
(State of Incorporation)
0-15443 58-1528626
(Commission File Number) (I.R.S. Employer Identification No.)
5325 Oakbrook Parkway, Norcross, Georgia 30093
(Address of Principal Executive Offices) (Zip Code)
(404) 381-8338
(Registrant's Telephone Number, Including Area Code)
<PAGE>
Item 5. Other Events
Announcement of Annual Meeting of Stockholders
Theragenics' Annual Meeting of Stockholders will be held Friday, June 6, 1997,
at 10:00 A.M., Atlanta time, at the Gwinnett Civic & Cultural Center, 6400
Sugarloaf Parkway, Duluth, Georgia 30136. The purpose of this meeting is to
elect two directors (six directors constitute the entire board), to consider and
vote on a proposal to ratify the appointment of independent public accountants,
to consider and act upon a proposal to approve and adopt the company's 1997
Stock Option Plan and transact orther business adopt the Company's 1997 Stock
Option Plan and to transact other business as may properly come before the
meeting or any adjournments thereof. The Board of Directors has fixed the close
of business on April 11, 1997, as the record date for the determination of the
stockholders entitled to notice of, and to vote at, the meeting. It is
anticipated that the Proxy Statement, Proxy and Annual Report will be mailed to
stockholders entitled to notice of and to vote at the Annual Meeting on or about
April 30, 1997.
This announcement serves to satisfy the public disclosure requirement of the
date of the Annual Meeting of Stockholders as addressed in the By-Laws of
Theragenics Corporation.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
THERAGENICS CORPORATION
/s/ Bruce W. Smith
Bruce W. Smith
Secretary, Treasurer and
Chief Financial Officer
Dated: March 26, 1997
